Literature DB >> 22698760

Low brain serotonin transporter binding in major depressive disorder.

Andrew B Newberg1, Jay D Amsterdam, Nancy Wintering, Justine Shults.   

Abstract

We examined midbrain, medial temporal lobe, and basal ganglia serotonin transporter (SERT) distribution volume ratio (DVR) values in subjects with major depressive disorder versus healthy volunteers using a selective SERT radioligand and single photon emission computed tomography (SPECT). We hypothesized that the DVR value for SERT binding would be lower in depressed versus non-depressed subjects. [(123)I]-ADAM SPECT scans were acquired from 20 drug free, depressed subjects and 20 drug-free depressed subjects and 10 drug-free healthy volunteers. The primary outcome measure was the DVR value for [(123)I]-ADAM uptake in the midbrain, medial temporal lobe, and basal ganglia regions. Depressed subjects demonstrated significantly lower DVR values in the midbrain, right and left medial temporal lobe, and right and left basal ganglia. There was significant probability that lower DVR values could distinguish between depressed and non-depressed subjects in the midbrain, medial temporal lobe, and the right and left basal ganglia. These findings confirm prior observations of lower SERT binding in depression, and suggest that low SERT binding may represent a putative biomarker of depression. Future studies are needed to confirm these observations.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22698760      PMCID: PMC3398160          DOI: 10.1016/j.pscychresns.2011.12.015

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  50 in total

1.  2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand.

Authors:  S Oya; S R Choi; C Hou; M Mu; M P Kung; P D Acton; M Siciliano; H F Kung
Journal:  Nucl Med Biol       Date:  2000-04       Impact factor: 2.408

2.  Distribution volume ratio of serotonin and dopamine transporters in euthymic patients with a history of major depression - a dual-isotope SPECT study.

Authors:  Pei Chun Hsieh; I Hui Lee; Tzung Lieh Yeh; Kao Chin Chen; Hui Chun Huang; Po See Chen; Yen Kuang Yang; Wei Jen Yao; Ru-Band Lu; Nan Tsing Chiu
Journal:  Psychiatry Res       Date:  2010-10-27       Impact factor: 3.222

Review 3.  Emotion and cortical-subcortical function: conceptual developments.

Authors:  M R Bennett; P M S Hacker
Journal:  Prog Neurobiol       Date:  2005-01       Impact factor: 11.685

4.  Cerebral serotonin transporter binding is inversely related to body mass index.

Authors:  D Erritzoe; V G Frokjaer; M T Haahr; J Kalbitzer; C Svarer; K K Holst; D L Hansen; T L Jernigan; S Lehel; G M Knudsen
Journal:  Neuroimage       Date:  2010-04-09       Impact factor: 6.556

5.  Seasonal changes in brain serotonin transporter binding in short serotonin transporter linked polymorphic region-allele carriers but not in long-allele homozygotes.

Authors:  Jan Kalbitzer; David Erritzoe; Klaus K Holst; Finn A Nielsen; Lisbeth Marner; Szabolcs Lehel; Tine Arentzen; Terry L Jernigan; Gitte M Knudsen
Journal:  Biol Psychiatry       Date:  2010-01-27       Impact factor: 13.382

6.  Decreased brain serotonin transporter binding in the euthymic state of bipolar I but not bipolar II disorder: a SPECT study.

Authors:  Yuan-Hwa Chou; Shyh-Jen Wang; Chun-Lung Lin; Wei-Chung Mao; Shin-Min Lee; Mei-Hsiu Liao
Journal:  Bipolar Disord       Date:  2010-05       Impact factor: 6.744

7.  Serotonin-transporter-linked promoter region polymorphism and serotonin transporter binding in drug-naïve patients with major depression.

Authors:  Mikko Joensuu; Soili Marianne Lehto; Tommi Tolmunen; Pirjo Irmeli Saarinen; Minna Valkonen-Korhonen; Ritva Vanninen; Pasi Ahola; Jari Tiihonen; Jyrki Kuikka; Ullamari Pesonen; Johannes Lehtonen
Journal:  Psychiatry Clin Neurosci       Date:  2010-08       Impact factor: 5.188

8.  [123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder.

Authors:  M Willeit; N Praschak-Rieder; A Neumeister; W Pirker; S Asenbaum; O Vitouch; J Tauscher; E Hilger; J Stastny; T Brücke; S Kasper
Journal:  Biol Psychiatry       Date:  2000-03-15       Impact factor: 13.382

9.  Serotonin transporter binding with [123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender.

Authors:  Henricus G Ruhé; Jan Booij; Johannes B Reitsma; Aart H Schene
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-30       Impact factor: 9.236

10.  Association between serotonin transporter availability and overall rating scores of quality of life in healthy volunteers.

Authors:  Hsin Chun Tsai; Tzung Lieh Yeh; Ming Hong Hsieh; I Hui Lee; Kao Ching Chen; Po See Chen; Yen Kuang Yang; Wei Jen Yao
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-03-28       Impact factor: 5.067

View more
  13 in total

1.  Effects of Shugan Jianpi Formula () on myeloid-derived suppression cells-mediated depression breast cancer mice.

Authors:  Yu-Tong Lu; Jie Li; Xin Qi; Ying-Xia Pei; Wen-Guang Shi; Hong-Sheng Lin
Journal:  Chin J Integr Med       Date:  2016-10-28       Impact factor: 1.978

2.  A positron emission tomography study of the serotonergic system in relation to anxiety in depression.

Authors:  Zafer Iscan; Gopalkumar Rakesh; Samantha Rossano; Jie Yang; Mengru Zhang; Jeffrey Miller; Gregory M Sullivan; Priya Sharma; Matthew McClure; Maria A Oquendo; J John Mann; Ramin V Parsey; Christine DeLorenzo
Journal:  Eur Neuropsychopharmacol       Date:  2017-08-12       Impact factor: 4.600

3.  Brain serotonin transporter binding, plasma arachidonic acid and depression severity: A positron emission tomography study of major depression.

Authors:  Manesh Gopaldas; Francesca Zanderigo; Serena Zhan; R Todd Ogden; Jeffrey M Miller; Harry Rubin-Falcone; Thomas B Cooper; Maria A Oquendo; Gregory Sullivan; J John Mann; M Elizabeth Sublette
Journal:  J Affect Disord       Date:  2019-07-05       Impact factor: 4.839

4.  Change over time in brain serotonin transporter binding in major depression: effects of therapy measured with [(123) I]-ADAM SPECT.

Authors:  Jay D Amsterdam; Andrew B Newberg; Cory F Newman; Justine Shults; Nancy Wintering; Irene Soeller
Journal:  J Neuroimaging       Date:  2013-06-10       Impact factor: 2.486

5.  Incongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAM.

Authors:  Yi-Wei Yeh; Pei-Shen Ho; Chun-Yen Chen; Shin-Chang Kuo; Chih-Sung Liang; Kuo-Hsing Ma; Chyng-Yann Shiue; Wen-Sheng Huang; Cheng-Yi Cheng; Tzu-Yun Wang; Ru-Band Lu; San-Yuan Huang
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

6.  Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.

Authors:  Yi-Wei Yeh; Pei-Shen Ho; Shin-Chang Kuo; Chun-Yen Chen; Chih-Sung Liang; Che-Hung Yen; Chang-Chih Huang; Kuo-Hsing Ma; Chyng-Yann Shiue; Wen-Sheng Huang; Jia-Fwu Shyu; Fang-Jung Wan; Ru-Band Lu; San-Yuan Huang
Journal:  Int J Neuropsychopharmacol       Date:  2015-01-07       Impact factor: 5.176

7.  N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data.

Authors:  Daniel A Monti; George Zabrecky; Daniel Kremens; Tsao-Wei Liang; Nancy A Wintering; Jingli Cai; Xiatao Wei; Anthony J Bazzan; Li Zhong; Brendan Bowen; Charles M Intenzo; Lorraine Iacovitti; Andrew B Newberg
Journal:  PLoS One       Date:  2016-06-16       Impact factor: 3.240

8.  Neurobiology of Chronic Stress-Related Psychiatric Disorders: Evidence from Molecular Imaging Studies.

Authors:  Margaret T Davis; Sophie E Holmes; Robert H Pietrzak; Irina Esterlis
Journal:  Chronic Stress (Thousand Oaks)       Date:  2017-06-22

9.  123I-ADAM SPET imaging of serotonin transporter in patients with epilepsy and comorbid depression.

Authors:  Maarika Liik; Malle Paris; Liina Vahter; Katrin Gross-Paju; Sulev Haldre
Journal:  BMC Neurol       Date:  2013-12-17       Impact factor: 2.474

10.  Meta-analysis of molecular imaging of serotonin transporters in major depression.

Authors:  Gregor Gryglewski; Rupert Lanzenberger; Georg S Kranz; Paul Cumming
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-07       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.